BioElectronics Corporation’s Patented ActiPatch(R) Therapy and Allay(TM) Patches Are Safe and Effective Alternatives to Acetaminophen

FREDERICK, MD--(Marketwire - July 01, 2009) -

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today released the following statements from the management team and leading physicians regarding the recent FDA panel recommendation to lower the maximum daily dosage of acetaminophen and to restrict the sale of large acetaminophen dosages such as those contained in Extra Strength Tylenol®.

“We are developing significant momentum around the world in the use of both ActiPatch® Therapy and the Allay™ Menstrual Pain Relief Patch as a safe and effective alternative to acetaminophen,” said Andrew Whelan, CEO BioElectronics Corp. “Pulsed ElectroMagnetic Field (PEMF) Therapy has been proven safe and effective in hundreds of peer-reviewed scientific studies and is a strong alternative therapy for many types of musculoskeletal complaints and surgical recovery. We welcome the FDA panel’s findings that acetaminophen usage is potentially dangerous and should be restricted,” Whelan said. “We look forward delivering our proven safe and effective drug-free pain relief and healing technology to the American market as our clinical studies move toward conclusion.” Physicians experienced with the BioElectronics product line made the following comments.

Barry Eppley, M.D., D.M.D., Indianapolis Plastic Surgeon

“The use of BioElectronics’ RecoveryRx™ allows me to reduce my patients’ use of post-operative medications including Tylenol®. My clinical studies have also shown BioElectronic’s Allay technology to be a very safe and highly effective treatment alternative for dysmenorrhea (period pain), one of the most common types of pain experienced by most women. Congratulations to BioElectronics on the development of these drug-free, pain relieving technologies.”

David Genocov, M.D. Specialist in Craniomaxillofacial Surgery

“As a physician I am always concerned about the overuse of narcotics and NSAIDS. Whenever possible our role is to reduce the use of these medications. To this end I currently use PEMF therapy in the form of the ActiPatch as an adjunctive therapy in the post-operative environment. The use of these devices has allowed me to significantly reduce the use of narcotics and NSAIDs to control pain among my patient population.”

Sheena Kong, M.D. -- Internal Medicine

“More and more of my patients are seeking drug-free solutions to pain relief. Use of Tylenol and other OTC pain medications is problematic for many types of patients and NSAIDs are often not a safe option. In my practice I have found both the ActiPatch and Allay Period Relief Patch products to be safe and effective alternatives. I believe the panel’s recommendations are sound as many patients are unaware of the potential dangers of these drugs.”

About BioElectronics Corporation

BioElectronics Corporation is the maker of patented ActiPatch® Therapy, RecoveryRx™ Devices, HealFast™ Therapy (www.healfasttherapy.com) and Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. These devices utilize embedded battery operated microchips to deliver weeks of home therapy for only about a dollar a day. The unique delivery system, using patented technology, provides a cost effective patient friendly method to reduce soft tissue pain and swelling. ActiPatch Therapy is approved by Health Canada for the relief of pain and musculoskeletal complaints. The US government food and drug administration (FDA) has cleared the use of the product for reducing edema (swelling) following blepharoplasty and the European Union has approved the product as a Class II pulsed electromagnetic medical device as have numerous other international agencies. For more information please see http://www.BioElectronicsCorp.com.

ActiPatch is a registered trademark of BioElectronics Corporation.

RecoveryRx, HealFast, and Allay are trademarks of BioElectronics Corporation.

Tylenol is a registered trademark of McNeil pharmaceutical, Inc.

Extra Strength Tylenol is a registered trademark of McNeil pharmaceutical, Inc.